About this trial
Temporomandibular disorder (TMD) is a common condition with multifactorial etiology, including trauma, emotional stress, parafunctional habits, and occlusal discrepancies. TMD may be classified as myogenous, involving the masticatory and cervical muscles, or arthrogenous, affecting the temporomandibular joint structures. Management approaches range from noninvasive to invasive methods. The intraoral stabilization appliance (SA) is a widely used noninvasive treatment, while the ear stent (ES) has recently been introduced for managing myogenous TMD.
Aim: This randomized clinical trial aims to compare the effectiveness of SA and ES in the management of myogenous TMD.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Participants presenting with pain score grading at least 4 out of 10 on NRS.
Participants with fully dentate type I occlusion.
Patients experiencing no neurological disorders.
Disqualifiers
Patients with arthrogenous TMJ will be excluded by Magnetic Resonance Imagining (MRI)
Patients who have clicking or crepitation.
Previous history of TMD treatment.
History of recent trauma.
Trial design
Parallel
Treatments tested in this trial
Stabilization Appliance
Other interventionParticipants will receive a maxillary stabilization appliance fabricated from 2-mm hard thermoplastic material using diagnostic casts. The appliance fit will be verified, and patients will be instructed to wear it for 3 months.
Ear Stent
Other interventionParticipants will undergo ENT evaluation prior to ear impression taking. Custom ear stents will be fabricated from soft addition silicone and hollowed to prevent hearing impairment.
Treatment groups
Trial outcomes
Primary outcomes
Change in Muscle activity
surface electromyography will be used to assess the temporalis and masseter muscles. The electrodes detect the electrical potentials generated by muscle fibers when they contract. This electrical activity is amplified and recorded by an electromyograph machine
Change in mouth opening
Measure the distance (in mm) between the incisal edge of the maxillary and mandibular central incisors
Secondary outcomes
Change in pain
NRS will be measured from the patient mark from 0 to 10, where 0 representing no pain and 10 representing the worst pain.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.